Health is our common task. Not only for states, but also for all citizens, — Dmitry Morozov, General Director, BIOCAD.
Mortality in hospitals remains high, if we talk about myocardial infarction and acute coronary syndrome, it is 13%. We have to reach the figure of 8%. This will be our contribution to a reduction in mortality, — Sergey Boytsov, Director, National Research Centre for Preventive Medicine of the Ministry of Health of the Russian Federation.
In the process of creating vascular departments in a number of regions, there was a restructuring of bed capacity, and other types of cardiac pathologies moved to the territory of therapeutic departments. We also have a poorly developed system of inter-district hospitals, — Sergey Boytsov, Director, National Research Centre for Preventive Medicine of the Ministry of Health of the Russian Federation.
The shortage of local staff is about 43%. Meanwhile, the functional centres are 96.6% staffed, — Andrey Kaprin, Director, National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation.
A healthy lifestyle will give results not in 2–3 years, but in 20–30. Pharmaceutical companies have the opportunity to help the patient today. Access in Russia to modern technologies and modern medicines is not as great as in other countries, — Pavol Dobrocky, Chief Executive Officer, Boehringer Ingelheim Russia.
“In Russia, 41% of the population has liver diseases. I want to draw attention to non-alcoholic fatty liver disease. It is socially significant, it has a huge reach throughout the world. According to 2014 studies, its distribution totals 37%, — Oksana Barvinok, Co-Founder and Director for Marketing, EXPERT Сlinic.
Introducing a systematic approach to the management of cardiovascular patients will reduce mortality by about 18% and give people 1.5 more years of life, — Vadim Vlasov, President, Novartis Group of Companies in Russia; Regional Director for Eastern and Central Europe and CIS, Novartis.
We have to move towards what is called a ‘smart hospital.’ There is a great desire from both business and development institutions, which are ready to invest huge amounts of money. We need initiatives on the ground, — Evgeniy Shlyakhto, Director General, Almazov National Medical Research Centre; President, All-Russian Non-Governmental Organization "Russian Society of Cardiology.
Without implementing scientific achievements, we will not solve the problem of reducing mortality. This is an important and fundamental question, — Alexander Rumyantsev, General Director, Dmitry Rogachev National Research Centre.
We need to introduce KPIs, which will tell us about the percentage of diabetes diagnoses, and what percentage of patients who have already been diagnosed are achieving their individual therapy goals, — Oksana Monge, General Director, Sanofi Russia.
In the modern world, diagnostics is key. Sometimes a diagnosis is tied to a specific drug. In Russia and other countries, the question is how we will provide this diagnosis, which allows us to correctly guide the patient and save money on treatment, — Andrey Potapov, Chief Executive Officer, Takeda Pharmaceuticals Russia.
In all clinical recommendations and treatment protocols, vaccination should be included as a preventative measure, as a means of prolonging life. Without this, we will not reach our targets, — Nikolay Briko, Head, Department of Epidemiology and Evidence-Based Medicine, Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation.
“At present, there is one heavyweight endocrinology centre in the country. It’s not enough for everyone. We very much want to have similar centres in the regions, so that high technologies are concentrated there. Such a centre may cost at least 200 million roubles. More advanced centres cost about a billion, — Marina Shestakova, Deputy Director, Endocrinology Research Centre of the Ministry of Health of the Russian Federation.
There is a whole group of people whose risk of morbidity is higher. In their regard, not only special medical measures, but also special measures in the field of improving public health should be taken, — Oleg Salagay, Deputy Minister of Healthcare of the Russian Federation.
“I want to emphasize the importance of the education and training of specialists in the field of prevention and control of non-communicable diseases. Mortality from NCDs can only be reduced by combining various ministries and departments, — Victoria Madianova, Director of the Department of International Health Projects, Higher School of Healthcare Management of the Institute of Leadership and Healthcare Management, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation.
We came up with the programme ‘Children Protecting Adults.’ We hold classes in schools. Through play, children learn to remember the symptoms of a stroke, — Ekaterina Milova, Development Director, ORBI Anti-Stroke Foundation.
Medical volunteers have a number of advantages. They really interact with people. They develop an individual approach to each age group, — Yulia Rakovskaya, Federal Coordinator for the Sanitary and Preventive Education of the Population, Medical Volunteers.